Across Europe, antibiotic resistance is making some H. pylori therapies less effective. That’s why prevention strategies need more than a “standard recipe”: they require monitoring resistance patterns, choosing the right regimens, and supporting adherence so people can complete treatment safely.
TOGAS supports building the evidence for effective, practical gastric cancer prevention approaches. So future screening and prevention strategies can be designed to work in real health systems.